Atreon Orthopedics earned FDA 510(k) clearance for the BioCharge autobiologic matrix and launched the new product, according to a Feb. 20 news release.
The EXODUS system is an advanced exosome isolation technology, offering significant improvements in yield, purity, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback